AzTrials
AzTrials

Sensorineural Hearing Loss, BilateralNCT03993899

Study of Quality Perception on Music in New Cochlear Implanted Subjects Using or Not a Fine Structure Strategy

A study testing FineHearing strategy or HDCIS strategy in people with Sensorineural Hearing Loss, Bilateral, run by MED-EL Elektromedizinische Geräte GmbH at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Main objective: Show the superiority of Fine Structure (FS4) strategy compared to Continuous Interleaved Sampling (HDCIS) strategy on the qualitative preference for the listening of musical pieces. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sensorineural Hearing Loss, Bilateral
What is being tested?
FineHearing strategy or HDCIS strategy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
1 siteFrance
Study dates
1 Jul 2019to 7 Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patient (≥ 18 years old) speaking French
  • Patient who fulfils the criteria for cochlear implantation

Who cannot join

  • Retro-cochlear pathology: auditory neuropathy, vestibular schwannoma

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Rennes

    Rennes, 35000

Other trials in France

About this study

Official title: Evaluation of the Impact of Coding the Fine Structure of the Sound on the Musical Perception in New Cochlear Implanted Subjects. Prospective Randomized Crossover Study.

Main objective:

Show the superiority of Fine Structure (FS4) strategy compared to Continuous Interleaved Sampling (HDCIS) strategy on the qualitative preference for the listening of musical pieces.

Read more

Secondary objectives

  • Show the superiority of FS4 strategy compared to the HDCIS strategy on the perception of musical elements (contour test).
  • Analyze the link between the results of musical perception tests and the subjective preference of musical listening.
  • Show the non inferiority of FS4 strategy compared to the HDCIS strategy on the perception of speech elements.
  • Analyze the link between the results of musical perception tests and the results of the perception of speech elements.
  • Analyze the qualitative multidimensional perception with HDCIS and FS4
Read the detailed description

Introduction:

At present, most people with modern cochlear implant systems can understand speech using the device alone, at least under favorable listening conditions.

In recent years, research has increasing focussed on how implant users perceive sounds other than speech. In particular, music perception is of interest.

A review of the literature on musical perception with traditional implants, coding only the temporal envelope [McDermott 2004], revealed the following elements:

  • On average, implant users perceive the rhythm approximately as well as listeners with normal hearing
  • With technically sophisticated multi-channel sound processors, melody recognition, especially without rhythmic or verbal cues, is poor.
  • The perception of timbre, especially the sounds of musical instruments, is generally unsatisfactory.
  • Implant users tend to rate the quality of musical sounds as less enjoyable than listeners with normal hearing And studies show that the fine structure of sound is the main vector of information for music and the location of sounds. [Smith et al. 2002] It therefore seems necessary to focus on the contribution of the coding of the fine temporal structure of sound to the cochlear implant.

Main objective:

Show the superiority of FS4 strategy compared to HDCIS strategy on the qualitative preference for the listening of musical pieces.

Secondary objectives:

  • Show the superiority of FS4 strategy compared to the HDCIS strategy on the perception of musical elements (contour test).
  • Analyze the link between the results of musical perception tests and the subjective preference of musical listening.
  • Show the non inferiority of FS4 strategy compared to the HDCIS strategy on the perception of speech elements.
  • Analyze the link between the results of musical perception tests and the results of the perception of speech elements.
  • Analyze the qualitative multidimensional perception with HDCIS and FS4

Plan of the study:

It is a prospective open monocentric randomized crossover study: measures will be done on the patient at 15 days and 30 days post-activation.

Being tested
FineHearing strategy or HDCIS strategy
Keywords
cochlear implant stimulation strategy sound coding strategy
Medical subject headings
Hearing Loss, Sensorineural

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FineHearing strategy or HDCIS strategyDevice

    Cochlear implant with FineHearing strategy or HDCIS strategy

Study groups in NCT03993899
Study groupRoleWhat they receive
Cochlear implant (CI) with FineHearing Strategy then HDCISActive comparatorcochlear implant with FineHearing strategy first during 15 days then with HDCIS strategy during 15 days
Receives: Device: FineHearing strategy or HDCIS strategy
CI with HDCIS Strategy then FS4Active comparatorcochlear implant with HDCIS strategy first during 15 days then with FS4 strategy during 15 days
Receives: Device: FineHearing strategy or HDCIS strategy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Qualitative measure of music

    The Gabrielsson scale (1988) is used to evaluate perceived sound quality as a multidimensional phenomenon, that is composed of a number of separate perceptual dimensions. Eight perceptual dimensions are evaluated: clarity, fullness, brightness vs dullness, hardness/sharpness vs softness, spaciousness, nearness, extraneous sounds, loudness. Visual analog scales (VAS) are used for each dimension and the patient has to score the dimension on a 10 cm VAS (between 0 to 10).

    Measured: at 15 days post-activation

  2. Qualitative measure of music

    The Gabrielsson scale (1988) is used to evaluate perceived sound quality as a multidimensional phenomenon, that is composed of a number of separate perceptual dimensions. Eight perceptual dimensions are evaluated: clarity, fullness, brightness vs dullness, hardness/sharpness vs softness, spaciousness, nearness, extraneous sounds, loudness. Visual analog scales are used for each dimension and the patient has to score the dimension on a 10 cm VAS (between 0 to 10).

    Measured: at 30 days post-activation

Secondary outcomes (6)
  1. Speech recognition in quiet

    The speech recognition in quiet is evaluated with syllabic list of 40 phonemes. The patient has to recognize 21 syllables. The phonemes are scored: each good answer is scored 1 yielding a total between 0 and 1 (or 0% and 100%).

    Measured: at 15 days post-activation

  2. Speech recognition in quiet

    The speech recognition in quiet is evaluated with syllabic list of 40 phonemes. The patient has to recognize 21 syllables. The phonemes are scored: each good answer is scored 1 yielding a total between 0 and 1 (or 0% and 100%).

    Measured: at 30 days post-activation

  3. Differential frequency threshold

    This test aimed to determine the smallest perceptible difference in F0 between two stimuli for various baseline values of F0. An adaptive procedure is used.

    Measured: at 15 days post-activation

  4. Differential frequency threshold

    This test aimed to determine the smallest perceptible difference in F0 between two stimuli for various baseline values of F0. An adaptive procedure is used.

    Measured: at 30 days post-activation

  5. Melodic contour test

    The test stimuli of the melodic contour test (Galvin et al. 2007) are melodic contours composed of 5 notes of equal duration whose frequencies corresponded to musical intervals. Nine distinct musical patterns have to be identified by the patient. Each good answer is scored 1 yielding a total between 0 and 1 (or 0% and 100%).

    Measured: at 15 days post-activation

  6. Melodic contour test

    The test stimuli of the melodic contour test (Galvin et al. 2007) are melodic contours composed of 5 notes of equal duration whose frequencies corresponded to musical intervals. Nine distinct musical patterns have to be identified by the patient. Each good answer is scored 1 yielding a total between 0 and 1 (or 0% and 100%).

    Measured: at 30 days post-activation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2019
  2. Study start1 Jul 2019
  3. Primary completion7 Jan 2020
  4. Study completion7 Jan 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Model description
two arms A and B: Arm A: patient's fitting with strategy FS4 --\> 15 days use --\> tests and patient's fitting with strategy HDCIS --\> 15 days use --\> tests Arm B: patient's fitting with strategy HDCIS --\> 15 days use --\> tests and patient's fitting with strategy FS4 --\> 15 days use --\> tests
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
19 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03993899
Sponsor's protocol ID
MED_EL_FS_music_Rennes_study
Status last verified
Jan 2020
First submitted
19 Jun 2019
Last updated
9 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing FineHearing strategy or HDCIS strategy in people with Sensorineural Hearing Loss, Bilateral, run by MED-EL Elektromedizinische Geräte GmbH at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Qualitative measure of music (time frame: at 15 days post-activation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in